. . "4.4 Zvl\u00E1\u0161tn\u00ED upozorn\u011Bn\u00ED a zvl\u00E1\u0161tn\u00ED opat\u0159en\u00ED pro pou\u017Eit\u00ED"@cs . . . "U pacient\u016F, kte\u0159\u00ED jsou l\u00E9\u010Deni syst\u00E9mov\u011B pod\u00E1van\u00FDmi chinolony, byly hl\u00E1\u0161eny z\u00E1va\u017En\u00E9 a n\u011Bkdy i fat\u00E1ln\u00ED reakce hypersensitivity (anafylaktick\u00E9 reakce), n\u011Bkdy dokonce i po prvn\u00ED d\u00E1vce. N\u011Bkter\u00E9 reakce byly doprov\u00E1zeny kardiovaskul\u00E1rn\u00EDm kolapsem, ztr\u00E1tou v\u011Bdom\u00ED, angioed\u00E9mem (v\u010Detn\u011B otoku hrtanu, hltanu nebo tv\u00E1\u0159e), obstrukc\u00ED d\u00FDchac\u00EDch cest, dyspnoe, kop\u0159ivkou a sv\u011Bd\u011Bn\u00EDm.\nDojde-li k\u00A0alergick\u00E9 reakci na p\u0159\u00EDpravek VIGAMOX O\u010CN\u00CD KAPKY, p\u0159eru\u0161te u\u017E\u00EDv\u00E1n\u00ED l\u00E9\u010Div\u00E9ho p\u0159\u00EDpravku. Z\u00E1va\u017En\u00E9 akutn\u00ED reakce hypersensitivity na moxifloxacin nebo jakoukoli jinou slo\u017Eku p\u0159\u00EDpravku mohou vy\u017Eadovat okam\u017Eitou pohotovostn\u00ED l\u00E9\u010Dbu. Tam, kde je to klinicky indikov\u00E1no, je t\u0159eba podat kysl\u00EDk a zajistit d\u00FDchac\u00ED cesty.\nPodobn\u011B jako u jin\u00FDch antiinfektiv m\u016F\u017Ee dlouhodob\u00E9 u\u017E\u00EDv\u00E1n\u00ED v\u00E9st k\u00A0p\u0159er\u016Fst\u00E1n\u00ED necitliv\u00FDch mikroorganism\u016F, v\u010Detn\u011B hub. Dojde-li k\u00A0superinfekci, p\u0159eru\u0161te pou\u017E\u00EDv\u00E1n\u00ED a zave\u010Fte alternativn\u00ED l\u00E9\u010Dbu.\n\u00DAdaje stanovuj\u00EDc\u00ED \u00FA\u010Dinnost a bezpe\u010Dnost p\u0159\u00EDpravku VIGAMOX O\u010CN\u00CD KAPKY p\u0159i l\u00E9\u010Db\u011B konjunktivitidy u novorozenc\u016F jsou velmi omezen\u00E9. Proto nen\u00ED tento p\u0159\u00EDpravek ur\u010Den k\u00A0l\u00E9\u010Db\u011B konjunktivitidy u novorozenc\u016F.\nP\u0159\u00EDpravek VIGAMOX O\u010CN\u00CD KAPKY by nem\u011Bl b\u00FDt pou\u017E\u00EDv\u00E1n k\u00A0profylaxi nebo empirick\u00E9 l\u00E9\u010Db\u011B gonokokov\u00E9 konjunktivitidy, v\u010Detn\u011B novorozeneck\u00E9 gonokokov\u00E9 konjunktivitidy, vzhledem k\u00A0v\u00FDskytu resistence fluorochinolon\u016F na Neisseria gonorrhoeae . Pacienti s\u00A0o\u010Dn\u00ED infekc\u00ED zp\u016Fsobenou Neisseria gonorrhoeae by m\u011Bli b\u00FDt l\u00E9\u010Den\u00ED odpov\u00EDdaj\u00EDc\u00ED syst\u00E9movou terapi\u00ED.\nP\u0159\u00EDpravek VIGAMOX O\u010CN\u00CD KAPKY se nedoporu\u010Duje pro l\u00E9\u010Dbu onemocn\u011Bn\u00ED vyvolan\u00E9ho mikroorganismem Chlamydia trachomatis u pacient\u016F mlad\u0161\u00EDch ne\u017E 2 roky, proto\u017Ee u t\u011Bchto pacient\u016F nebyl p\u0159\u00EDpravek hodnocen. Pacienti star\u0161\u00ED ne\u017E 2 roky s\u00A0o\u010Dn\u00ED infekc\u00ED zp\u016Fsobenou Chlamydia trachomatis by m\u011Bli b\u00FDt l\u00E9\u010Den\u00ED odpov\u00EDdaj\u00EDc\u00ED syst\u00E9movou terapi\u00ED.\nNovorozenci s\u00A0ophthalmia neonatorum by m\u011Bli b\u00FDt l\u00E9\u010Deni odpov\u00EDdaj\u00EDc\u00ED l\u00E9\u010Dbou vzhledem ke sv\u00E9mu stavu, nap\u0159\u00EDklad syst\u00E9movou l\u00E9\u010Dbou v\u00A0p\u0159\u00EDpadech vyvolan\u00FDch Chlamydia trachomatis a \nNeisseria gonorrhoeae.\nPacienti by m\u011Bli b\u00FDt informov\u00E1ni, \u017Ee nemaj\u00ED nosit kontaktn\u00ED \u010Do\u010Dky, pokud se u nich vyskytnou zn\u00E1mky a p\u0159\u00EDznaky bakteri\u00E1ln\u00ED o\u010Dn\u00ED infekce.\n"@cs . . . . . . "004.004" .